ArticleInternational medical case reports journal2025
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlay Associated with Self-Medication of Sulfadoxine-Pyrimethamine Overdose in a Patient with HIV/AIDS Infection: A Case Report.
Article in International medical case reports journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) overlap is a severe delayed-type hypersensitivity reaction causing widespread blistering and necrosis of skin and mucosa. Sulfadoxine-pyrimethamine (SP) and HIV/AIDS infection are associated with hypersensitivity reactions, including SJS and TEN. A 20-year-old female with HIV/AIDS presented with fever, body pain, and skin blisters on her face, neck, trunk, and perineum. She was non-compliant with antiretroviral therapy. The lesions developed three days after self-administering SP for malaria, taken as two tablets every 12 hours for three days. The skin involvement was 23% of total body surface area (TBSA). The Naranjo Adverse Drug Reaction Scale Score of four suggested a possible association between SP and SJS/TEN overlap, considering HIV/AIDS can precipitate this reaction. The severity-of-illness score of toxic epidermal necrolysis (SCORTEN) score was one, with predicted mortality of 3.2%. The patient received conservative treatment including fluids, antimicrobials, nutrition, and wound care, leading to complete recovery. It is imperative that the medicine regulatory authority and healthcare professionals educate HIV patients to avoid self-medication with antibiotics such as SP due to the increased risk of serious adverse drug reactions, including SJS/TEN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.